Live Quote · NASDAQNGNEHealthcare· Biotechnology

Neurogene Inc.

$22.15▼ 3.40%($-0.78)
MKT CAP $350.02MNEXT EARNINGS Mar 23, 2027
50%
Bullish
TickerSpark Score
49/100
▌ Weak
87
Valuation
20
Profitability
25
Growth
84
Health
30
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a NGNE research report →

Analyst Price Target
$72.00+225.1% vs. today

Range $65 – $81

Analyst RatingBuy
6 Buy1 Hold0 Sell

Price Chart

+8.58% · this period
$42.84$29.61$16.37Nov 20May 26Nov 20
52-Week Range22% of range
Low
$15.93
Current
$22.15
High
$43.66